Hepatocellular Carcinoma:

CHF 248.75
Auf Lager
SKU
1207OSDCQ61
Stock 1 Verfügbar
Geliefert zwischen Mi., 04.02.2026 und Do., 05.02.2026

Details

Hepatocellular Carcinoma: Targeted Therapy provides a detailed repository of the latest information regarding HCC epidemiology, diagnosis, imaging, pathology, staging, and treatment options. This volume also provides an up-to-date guide for treatment that explores not only traditional treatments, but newer investigational treatment options including, surgical resection, liver transplantation, ablation (radiofrequency, microwave), percutaneous ethanol or acetic acid injection, transarterial chemoembolization (TACE), intra-arterial radiation therapy, and systemic chemotherapy. Heptocellular Carcinoma: Targeted Therapy will be of great value to all health care professionals and trainees worldwide who have an interest in the diagnosis and treatment of HCC, including surgeons, medical oncologists, radiologists, radiation oncologists, and pathologists.

New targeted therapeutic procedures Advanced surgical procedures New investigational treatment options

Inhalt
Epidemiology and Pathogenesis of HCC.- HCC in patients without cirrhosis or hepatitis.-Pathology considerations.- Diagnosis of HCC: the role of imaging studies.- Screening Programs in High-Risk Populations.- Treatment Overview: Assembling a multidisciplinary team and selection of appropriate treatment options.- Evidence-based guidelines for treatment of HCC in Japan.- Liver Resection for HCC.- Portal Vein Embolization prior to resection.- Laparoscopic Liver Resection for HCC.- Liver Transplantation for HCC.- Resection and reconstruction of inferior vena cava and hepatic veins for advanced HCC.- Radiofrequency ablation for HCC.- Microwave ablation.- Transarterial Chemoembolization.- Intra-arterial chemotherapy bead therapy.- Radioactive microsphere therapy.-Targeted Therapies for HCC.- Systemic Therapy Options for HCC.- Patient follow-up strategies and salvage therapy for recurrence.

Weitere Informationen

  • Allgemeine Informationen
    • Sprache Englisch
    • Editor Kelly M. McMasters
    • Titel Hepatocellular Carcinoma:
    • Veröffentlichung 02.12.2010
    • ISBN 1603275215
    • Format Fester Einband
    • EAN 9781603275217
    • Jahr 2010
    • Größe H241mm x B160mm x T31mm
    • Untertitel Targeted Therapy and Multidisciplinary Care
    • Gewicht 890g
    • Auflage 2011
    • Genre Medizin
    • Lesemotiv Verstehen
    • Anzahl Seiten 432
    • Herausgeber Springer New York
    • GTIN 09781603275217

Bewertungen

Schreiben Sie eine Bewertung
Nur registrierte Benutzer können Bewertungen schreiben. Bitte loggen Sie sich ein oder erstellen Sie ein Konto.
Made with ♥ in Switzerland | ©2025 Avento by Gametime AG
Gametime AG | Hohlstrasse 216 | 8004 Zürich | Schweiz | UID: CHE-112.967.470
Kundenservice: customerservice@avento.shop | Tel: +41 44 248 38 38